Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital
NCT ID: NCT04177615
Last Updated: 2019-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
109 participants
INTERVENTIONAL
2019-11-19
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION
NCT05402878
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
NCT04170647
Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment
NCT02441556
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
NCT06211712
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thromboectomy and rTPA
use thromboectomy and rtpa for patient with basilar artery occlusion stroke in 24 hour
Thromboectomy
Thromboectomy in Basilar Artery Occlusion patients
rTPA( recombinant tissue plasminogen activator )
use rtpa for patient with basilar artery occlusion stroke in 24 hour
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thromboectomy
Thromboectomy in Basilar Artery Occlusion patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* NIHSS \> 4 points
Exclusion Criteria
* Patients with contraindication of either rTPA or thromboectomy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Medicine and Pharmacy at Ho Chi Minh City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tran Nguyen Uyen Dung
Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery occlusion stroke in 115 hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
TUAN D Tran, MD
Role: STUDY_CHAIR
UMP university
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
THANG H Nguyen, MD, PhD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
yds2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.